...
首页> 外文期刊>Journal of medical toxicology: official journal of the American College of Medical Toxicology >Impact of a Mandatory Prescription Drug Monitoring Program Check on Emergency Department Opioid Prescribing Rates
【24h】

Impact of a Mandatory Prescription Drug Monitoring Program Check on Emergency Department Opioid Prescribing Rates

机译:强制处方药监测方案检查对应急部门阿片类药物规定率的影响

获取原文
获取原文并翻译 | 示例

摘要

Background Prescription drug monitoring programs (PDMPs) exist in 49 states to guide opioid prescribing. In 40 states, clinicians must check the PDMP prior to prescribing an opioid. Data on mandated PDMP checks show mixed results on opioid prescribing. Objectives This study sought to examine the impact of the Massachusetts mandatory PDMP check on opioid prescribing for discharges from an urban tertiary emergency department (ED). Methods This was a retrospective cohort study of discharges from one ED from 7/1/2010-10/15/2018. The primary outcome was the monthly percentage of patients discharged from the ED with an opioid prescription. The intervention was Massachusetts mandating a PDMP check for all opioid prescriptions. Prescribing was compared pre- and post-mandate. Interrupted time series (ITS) analysis accounted for known declining trends in opioid prescribing. Results Of 273,512 ED discharges, 35,050 (12.8%) received opioid prescriptions. Mean monthly opioid prescribing decreased post-intervention from 15.1% (SD ± 3.5%) to 5.1% (SD ± 0.9%;p < 0.001). ITS showed equal pre and post-intervention slopes (-0.002, p = 0.819). A small immediate decrease occurred in prescribing around the mandated check: a 3-month level effect decrease of 0.018 (p = 0.039), 6-month level effect 0.019 (p = 0.023), and a 12-month level effect of 0.020 (p = 0.019). The 24-month level effect was not decreased. Conclusion Prior to the mandated PDMP check, ED opioid prescribing was declining. The mandate did not change the rate of decline but was associated with a non-sustained drop in opioid prescribing immediately following enactment.
机译:背景:49个州都有处方药监测计划(PDMP)来指导阿片类药物的处方。在40个州,临床医生在开阿片类药物之前必须检查PDMP。强制性PDMP检查的数据显示,阿片类药物处方的结果喜忧参半。目的本研究旨在探讨马萨诸塞州强制性PDMP检查对城市三级急诊科(ED)出院患者阿片类药物处方的影响。方法对2010年1月7日至2018年10月15日的一次急诊出院进行回顾性队列研究。主要结果是每月使用阿片类药物处方从急诊室出院的患者百分比。干预措施是马萨诸塞州强制对所有阿片类处方进行PDMP检查。在授权前和授权后对处方进行比较。中断时间序列(ITS)分析解释了阿片类药物处方的已知下降趋势。结果在273512例急诊出院患者中,35050例(12.8%)接受了阿片类处方。干预后平均每月阿片类药物处方从15.1%(标准差±3.5%)降至5.1%(标准差±0.9%;p<0.001)。ITS显示干预前后的斜率相等(-0.002,p=0.819)。强制检查前后的处方量立即出现小幅下降:3个月水平效应下降0.018(p=0.039),6个月水平效应下降0.019(p=0.023),12个月水平效应下降0.020(p=0.019)。24个月的水平效应没有降低。结论在强制性PDMP检查之前,ED类阿片处方正在减少。这项授权并没有改变下降的速度,但与颁布后阿片类药物处方的非持续下降有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号